The pre-treatment priorities
- Know the trade name, manufacturer, material, intended area, preparation and local label—not only the word “collagen booster.”
- Check the exact product in Thailand’s official database and see its intact box, Thai label, lot and expiry details.
- Give the doctor a complete health, allergy, medicine and previous-procedure history; do not stop prescribed medicine yourself.
- Discuss infection, inflammation, dental problems and other planned facial treatments without assuming one universal waiting interval.
- Understand that most particle-based biostimulators are not reversed like hyaluronic-acid filler.
- Leave with written aftercare, follow-up and an urgent-contact plan for the exact product and injection area.
Identify the material—and the exact product
PLLA (poly-L-lactic acid), CaHA (calcium hydroxylapatite), PCL (polycaprolactone) and PDLLA (poly-D,L-lactic acid) are not synonyms. A product may be a powder to reconstitute, particles in a gel carrier or a hybrid. Preparation, injection plane, approved area and evidence change by product and country; one product should not inherit another’s label or instructions.
This group is not simply HA filler with a slower result. HA gel primarily provides physical filling or support and can often be reduced with hyaluronidase. Particle-based biostimulators produce a tissue response, sometimes with an earlier carrier effect. Hyaluronidase does not dissolve PLLA, CaHA, PCL or PDLLA particles. In a hybrid, it may affect an HA component without removing the entire implant.
Check Thai registration, the label and the box
Search the exact trade name and registration details in the Thai FDA product database. Match the manufacturer, model or formulation and labelled use; a similar name, a distributor’s post or a US approval is not proof of Thai authorization. US Sculptra and Radiesse instructions are useful for understanding those specific products, but they do not establish the Thai label for them—or for any PCL, PDLLA or hybrid product.
Before opening, see the intact packaging, legible Thai label, lot and expiry. Request a record of the product, amount, preparation, area and lot; photograph the box if permitted. If the product changes on procedure day, revisit consent.
Get the treating doctor’s full name and verify it through the Medical Council of Thailand. Check the facility through the Department of Health Service Support, and ask about experience with the exact product and area.
Share health, medicine and skin history completely
Disclose severe allergies or anaphylaxis, anaesthetic reactions, bleeding or clotting disorders, immune conditions or treatment, poorly controlled illness, abnormal scarring, recurrent herpes, implant reactions and poor wound healing. List every prescription, over-the-counter medicine, injection, vitamin, herb and supplement. Some can affect bleeding or bruising, but that calls for clinician-led planning—not self-discontinuation.
Do not stop aspirin, an anticoagulant, steroid or another prescription to qualify for treatment; the procedural doctor and prescriber should decide any change. Report active acne, rash, hives, cold sore, wound, fever or nearby infection. The cited Sculptra and Radiesse US labels advise deferring injection at a site with active inflammation or infection until it is controlled.
Map previous injectables, surgery, dental work and devices
List previous HA filler, biostimulator, permanent injectable, threads, implants, facial surgery, trauma and complications—even if the product name is missing. Bring records or photographs when available. Existing material or scar tissue may alter anatomy and planning; Sculptra’s US instructions note that safety at sites previously injected with other fillers has not been evaluated.
Also mention recent or planned dental work, tooth or gum infection, laser, peel, microneedling, RF, ultrasound or other energy treatment. Delayed inflammation near filler sites has been reported after illness, infection, vaccination and dental procedures, while product labels warn about treatment before skin has healed after a procedure that creates an active dermal response. These observations do not create one evidence-based waiting period for everyone. Timing should reflect the exact product, site, skin healing, oral health and planned procedure.
Pregnancy and breastfeeding: an evidence gap
Tell the doctor if you are pregnant, might be pregnant, are planning pregnancy or are breastfeeding. US Sculptra instructions say safety and effectiveness have not been evaluated in these groups; the US FDA likewise describes soft-tissue filler safety as unknown. For an elective treatment, discuss postponement and the exact local label rather than treating missing evidence as proof of safety.
Consent, baseline photographs and realistic expectations
The consultation should identify the problem—volume loss, skin quality, laxity, a fold or several causes—and why this product and tissue plane fit better than HA filler, an energy device, surgery or no procedure. Ask what may change, when it will be assessed and what would count as insufficient response. Reject guaranteed improvement, fixed duration or a universal session package.
Take standardized baseline photographs in consistent lighting before treatment. Consent should cover common injection reactions, asymmetry, infection, delayed inflammation, persistent papules or nodules, vascular occlusion, tissue injury, visual loss and stroke, as relevant to the product and site. It should also explain whether the proposed use is within the exact Thai label and what evidence supports any off-label plan. Permission to use identifiable images for marketing should be separate from consent to treatment.
Plan reversibility, massage and aftercare before injection
Ask what happens if the result is uneven, excessive or develops a delayed lump. PLLA, CaHA, PCL and PDLLA have no universal enzyme that removes their particles; management depends on the diagnosis and may be difficult. “It can always be dissolved” is not adequate consent.
Obtain written aftercare for the exact product. Current US Sculptra instructions include product-specific massage advice, but that routine must not be copied automatically to Radiesse, PCL, PDLLA or a hybrid. Ask whether massage applies, how it should be done, what symptoms mean stop, when the review occurs and when other skin, dental or energy procedures can be reconsidered. Read our product-specific biostimulator aftercare guide before procedure day.
Agree on emergency and follow-up routes
Know who reviews an early concern, how to reach a clinician after hours and where vascular or visual symptoms are assessed. Unusual or escalating pain; pale, white, grey, blue or mottled skin; eye pain or vision change; facial or limb weakness or numbness; difficulty speaking, confusion, severe headache or trouble walking need immediate care. Breathing difficulty, throat tightness, faintness, or rapid tongue or lip swelling—especially with widespread hives—may indicate anaphylaxis and is also an emergency. In Thailand, call 1669.
Keep the box and lot record, photographs and written plan for routine follow-up and any delayed concern. A booking-only chat account is not a substitute for a named clinician and escalation route.
Questions worth taking to the consultation
- What is the exact product, material, manufacturer and Thai registration—and is this area within its local label?
- How will it be prepared, diluted and placed, and why does that plan fit my anatomy?
- What prior injectables, surgery, dental issues or energy procedures change the decision?
- Does any medicine need review with its prescriber, rather than being stopped by me?
- What is known—and not known—about this product’s result, duration and complications?
- If a lump, asymmetry or vascular concern occurs, who assesses it and what options actually exist?
- What written aftercare, massage instruction, routine review and urgent contact will I receive?
The bottom line
Before a biostimulator, verify the exact product, disclose health and procedure history, understand the local label and limited reversibility, and agree on follow-up. PLLA, CaHA, PCL and PDLLA should not borrow one another’s claims or aftercare. A careful plan says what will be used, why it fits, what remains uncertain and what happens if recovery is unexpected.